N. A. Kanitez Et Al. , "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database," EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4, pp.206-211, 2022
Kanitez, N. A. Et Al. 2022. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4 , 206-211.
Kanitez, N. A., KİRAZ, S., Dalkilic, E., Kimyon, G., Mercan, R., KARADAĞ, Ö., ... Bes, C.(2022). The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database. EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4, 206-211.
Kanitez, Nilufer Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database," EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4, 206-211, 2022
Kanitez, Nilufer A. Et Al. "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4, pp.206-211, 2022
Kanitez, N. A. Et Al. (2022) . "The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database." EUROPEAN JOURNAL OF RHEUMATOLOGY , no.4, pp.206-211.
@article{article, author={Nilufer Alpay Kanitez Et Al. }, title={The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2022, pages={206-211} }